Our findings suggest that the inhibition of RHCG and TRPA1 enhances the sensitivity of lung cancer cells to radiation and may provide a new target for the combination of radiotherapy and immunotherapy for lung cancer treatment. This evidence concerns the gene TRPA1 and lung carcinoma.